Sort   by:  
 Page size 
UnknownLong-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma.
Not available
S-EPMC9015786 | biostudies-literature
UnknownClinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018).
Not available
S-EPMC9541514 | biostudies-literature
UnknownRuxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis.
Not available
S-EPMC9293486 | biostudies-literature
UnknownA real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome.
Not available
S-EPMC9327542 | biostudies-literature
UnknownUtility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy.
Not available
S-EPMC4598254 | biostudies-literature
UnknownCardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes.
Not available
S-EPMC12686793 | biostudies-literature
UnknownCell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.
Not available
S-EPMC12624761 | biostudies-literature
UnknownBenefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma
Not available
S-EPMC12927045 | biostudies-literature
Sort   by:  
 Page size